NCAPD2 and breast carcinoma: For the first time in this study, we used a comprehensive in silico approach and identified five proto-oncogenes (TUBA1B, SLC2A1, PGK1, CCND1, and NCAPD2) and two tumor suppressor genes (RPLP2, RPL37) as novel therapeutic targets against breast cancer.